BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 31542510)

  • 1. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
    Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
    Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
    Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
    Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
    Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
    Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
    Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
    Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
    Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
    Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
    Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
    J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
    Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
    J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
    Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
    J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
    Ghantous Y; Bahouth Z; Abu El-Naaj I
    Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
    Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
    Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
    Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
    Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
    Melis M; Zhang T; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
    Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
    Elife; 2020 Sep; 9():. PubMed ID: 32990596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.